Ibrance 125mg Capsules
Overview
What is this medicine?
How to Use This Medicine
To ensure you get the most benefit from your medication, follow these steps:
Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
Take your medication with food to help your body absorb it properly.
Swallow the medication whole - do not chew, open, or crush it.
Check your medication before taking it. If it is broken, cracked, or looks damaged, do not take it.
Take your medication at the same time every day to establish a routine.
Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.
What to Do If You Vomit After Taking a Dose
If you throw up after taking a dose, do not take an extra dose. Instead, wait until your next scheduled dose and take it as usual.
Storing and Disposing of Your Medication
To keep your medication safe and effective:
Store it at room temperature in a dry place, away from the bathroom.
* Keep all medications in a safe location, out of the reach of children and pets.
Missing a Dose
If you miss a dose, skip it and go back to your regular schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take Ibrance capsules whole with food, at approximately the same time each day.
- Do not chew, crush, or open the capsules.
- If you miss a dose or vomit after taking a dose, do not take an extra dose. Take the next dose at your regularly scheduled time.
- Avoid grapefruit and grapefruit products during treatment, as they can increase the amount of Ibrance in your body.
- Avoid St. John's Wort during treatment.
- Use effective contraception during treatment and for at least 3 weeks after the last dose for women, and for at least 3 months after the last dose for men.
- Report any signs of infection (fever, chills, sore throat) immediately to your doctor.
- Report any new or worsening shortness of breath or cough.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of bleeding, such as:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Dizziness
Lung problems, which can be life-threatening. Seek medical help immediately if you experience:
+ Chest pain
+ Cough with or without mucus
+ Shortness of breath or other breathing difficulties
Blood clots, which can be life-threatening. Seek medical help immediately if you experience:
+ Chest pain or pressure
+ Coughing up blood
+ Shortness of breath
+ Swelling, warmth, numbness, color change, or pain in a leg or arm
+ Difficulty speaking or swallowing
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects, contact your doctor or seek medical attention if they bother you or persist:
Hair loss
Hair thinning
Mouth irritation or mouth sores
Fatigue or weakness
Dry skin
Changes in taste
Diarrhea
Nausea or vomiting
Upset stomach
Decreased appetite
These side effects are common with this medication. If you experience any of them, talk to your doctor about ways to manage them. Seek medical help immediately if any of these side effects are severe, worsen, or persist.
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever (especially 100.4°F or higher) or chills
- Signs of infection (e.g., sore throat, cough, painful urination)
- Unusual bruising or bleeding
- Extreme tiredness or weakness
- Shortness of breath or difficulty breathing
- Persistent cough
- Severe nausea, vomiting, or diarrhea
- Mouth sores (stomatitis)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Any medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, that may interact with this medication. Certain medications used to treat HIV, infections, seizures, and other conditions should not be taken with this drug.
If you are breastfeeding or plan to breastfeed. You should not breastfeed while taking this medication and for 3 weeks after your last dose.
Please note that this is not an exhaustive list of all potential interactions or health problems that may affect the use of this medication. To ensure your safety, it is crucial to:
Inform your doctor and pharmacist about all your medications (prescription and OTC), natural products, vitamins, and health problems.
Verify that it is safe to take this medication with all your other medications and health conditions.
Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
While taking this drug, you may be at a higher risk of developing infections, some of which can be severe or even life-threatening. To minimize this risk, practice good hygiene by washing your hands frequently and avoid close contact with individuals who have infections, colds, or flu.
You may also experience an increased tendency to bleed easily. To reduce the risk of injury, exercise caution in your daily activities and use a soft toothbrush and an electric razor for personal grooming.
Regular blood tests and other laboratory evaluations are crucial while taking this medication. Ensure that you adhere to the schedule recommended by your doctor for these tests.
This drug is often administered in conjunction with other medications. It is vital to understand the warnings, benefits, and risks associated with these additional drugs. If you have any questions or concerns, discuss them with your doctor.
Avoid consuming grapefruit and grapefruit juice during treatment with this medication.
Men taking this drug should be aware that it may affect their fertility. Discuss any concerns with your doctor.
For women, this drug may cause harm to an unborn baby. A pregnancy test will be conducted before initiating treatment to confirm that you are not pregnant. If you are capable of becoming pregnant, use effective birth control methods while taking this medication and for at least 3 weeks after your last dose. If you become pregnant, notify your doctor immediately.
If your partner may become pregnant, use birth control while taking this drug and for 3 months after your last dose. If your partner becomes pregnant, contact the doctor right away.
Overdose Information
Overdose Symptoms:
- Increased severity of known adverse reactions, particularly myelosuppression (low white blood cell count, low platelet count).
What to Do:
There is no specific antidote for palbociclib overdose. Management should involve general supportive measures. Contact a poison control center (1-800-222-1222) or seek immediate medical attention.
Drug Interactions
Major Interactions
- Strong CYP3A Inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, grapefruit juice): Significantly increase palbociclib exposure. Avoid concomitant use. If unavoidable, reduce palbociclib dose.
- Strong CYP3A Inducers (e.g., rifampin, phenytoin, carbamazepine, St. John's Wort): Significantly decrease palbociclib exposure. Avoid concomitant use.
Moderate Interactions
- Moderate CYP3A Inhibitors (e.g., erythromycin, diltiazem, verapamil, fluconazole): May increase palbociclib exposure. Consider dose reduction if adverse reactions occur.
- Moderate CYP3A Inducers (e.g., bosentan, efavirenz, etravirine, modafinil, nafcillin): May decrease palbociclib exposure. Avoid if possible.
Monitoring
Baseline Monitoring
Rationale: To establish baseline hematologic parameters, especially neutrophil and platelet counts, as neutropenia and thrombocytopenia are common adverse reactions.
Timing: Prior to initiation of treatment
Rationale: To establish baseline liver function, as hepatic impairment may require dose adjustment and liver enzyme elevations can occur.
Timing: Prior to initiation of treatment
Routine Monitoring
Frequency: Prior to the start of each cycle, on Day 15 of the first 2 cycles, and as clinically indicated.
Target: Neutrophils ≥1000/mm³, Platelets ≥50,000/mm³ for cycle initiation.
Action Threshold: Neutrophils <1000/mm³ or platelets <50,000/mm³ require dose interruption or reduction.
Frequency: Periodically, as clinically indicated.
Target: Within normal limits or stable.
Action Threshold: Significant elevations may require dose interruption or reduction.
Symptom Monitoring
- Fever or other signs of infection (e.g., chills, sore throat, cough)
- Unusual bruising or bleeding
- Fatigue or weakness
- Shortness of breath or cough (signs of interstitial lung disease/pneumonitis)
- Nausea, vomiting, diarrhea
- Stomatitis (mouth sores)
Special Patient Groups
Pregnancy
Ibrance can cause fetal harm when administered to a pregnant woman. Based on animal studies and its mechanism of action, palbociclib can cause embryo-fetal toxicity. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment and for at least 3 weeks after the last dose. Advise males with female partners of reproductive potential to use effective contraception during treatment and for 3 months after the last dose.
Trimester-Specific Risks:
Lactation
It is not known whether palbociclib is excreted in human milk. Because of the potential for serious adverse reactions in breastfed infants from palbociclib, advise lactating women not to breastfeed during treatment and for 3 weeks after the last dose.
Pediatric Use
The safety and effectiveness of Ibrance in pediatric patients have not been established.
Geriatric Use
No overall differences in safety or effectiveness were observed between patients ≥65 years of age and younger patients. No dose adjustment is required based on age.
Clinical Information
Clinical Pearls
- Always administer palbociclib with food to optimize absorption and reduce variability.
- Neutropenia is the most common adverse event and is typically reversible and manageable with dose interruptions and/or reductions. Close monitoring of CBC is crucial.
- Patients should be educated on the importance of reporting any signs of infection, fever, or respiratory symptoms immediately.
- Strict adherence to the 21-days-on/7-days-off dosing schedule is important for efficacy and managing side effects.
- Counsel patients to avoid strong CYP3A inhibitors (e.g., grapefruit) and inducers (e.g., St. John's Wort).
Alternative Therapies
- Other endocrine therapies (e.g., fulvestrant, aromatase inhibitors alone)
- Chemotherapy (e.g., capecitabine, eribulin, paclitaxel)
- Other targeted therapies (e.g., everolimus + exemestane, alpelisib + fulvestrant for PIK3CA-mutated HR+/HER2- breast cancer)